PTC725
CAS No. 1248581-07-8
PTC725 ( PTC 725 )
产品货号. M11004 CAS No. 1248581-07-8
PTC725 is a potent, selective, and orally bioavailable inhibitor of HCV NS4B, inhibits HCV 1b (Con1) replicons with EC50 of 1.7 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥9477 | 有现货 |
|
50MG | ¥19278 | 有现货 |
|
100MG | ¥25110 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PTC725
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PTC725 is a potent, selective, and orally bioavailable inhibitor of HCV NS4B, inhibits HCV 1b (Con1) replicons with EC50 of 1.7 nM.
-
产品描述PTC725 is a potent, selective, and orally bioavailable inhibitor of HCV NS4B, inhibits HCV 1b (Con1) replicons with EC50 of 1.7 nM; displays a selectivity index of >5,000 with respect to cellular GAPDH, and >1,000-fold selectivity window with respect to cytotoxicity; retains fully activity against HCV replicon mutants that are resistant to inhibitors of NS3 protease and NS5B polymerase, demonstrates synergistic affect in combination with alpha interferon in vivo.
-
同义词PTC 725
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCV
-
研究领域——
-
适应症——
化学信息
-
CAS Number1248581-07-8
-
分子量518.49
-
分子式C23H18F4N6O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=S(C1=CC=C(C(N2C3=NC=CC=N3)=C(C#N)C4=C2C=C(CC)C(F)=C4)N=C1)(N[C@@H](C)C(F)(F)F)=O
-
化学全称(S)-6-(3-Cyano-6-ethyl-5-fluoro-1-(pyrimidin-2-yl)-1H-indol-2-yl)-N-(1,1,1-trifluoropropan-2-yl)pyridine-3-sulfonamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gu Z, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):3250-61.
2. Zhang N, et al. J Med Chem. 2014 Mar 13;57(5):2121-35.
3. Graci JD, et al. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7060-7066.
2. Zhang N, et al. J Med Chem. 2014 Mar 13;57(5):2121-35.
3. Graci JD, et al. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7060-7066.
产品手册
关联产品
-
Myriocin
Myriocin, a fungal metabolite isolated from Myriococcum albomyces, Isaria sinclairi and Mycelia sterilia, is a potent inhibitor of serine-palmitoyl-transferase (SPT) and a key enzyme in de novo synthesis of sphingolipids.
-
Filibuvir
Filibuvir (PF-00868554;PF-868554) is a nonnucleoside, potent and selective, orally available HCV NS5B inhibitor with IC50 of 19 nM, EC50 of 75 nM.
-
Paritaprevir (b)
Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.